141 related articles for article (PubMed ID: 9818315)
1. Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models.
Fossheim SL; Colet JM; Månsson S; Fahlvik AK; Muller RN; Klaveness J
Invest Radiol; 1998 Nov; 33(11):810-21. PubMed ID: 9818315
[TBL] [Abstract][Full Text] [Related]
2. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity.
Fossheim SL; Fahlvik AK; Klaveness J; Muller RN
Magn Reson Imaging; 1999 Jan; 17(1):83-9. PubMed ID: 9888401
[TBL] [Abstract][Full Text] [Related]
3. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
[TBL] [Abstract][Full Text] [Related]
4. Insights on the relaxation of liposomes encapsulating paramagnetic Ln-based complexes.
Mulas G; Ferrauto G; Dastrù W; Anedda R; Aime S; Terreno E
Magn Reson Med; 2015 Aug; 74(2):468-73. PubMed ID: 25186276
[TBL] [Abstract][Full Text] [Related]
5. Iron(III)-Based Magnetic Resonance-Imageable Liposomal T1 Contrast Agent for Monitoring Temperature-Induced Image-Guided Drug Delivery.
Kneepkens E; Fernandes A; Nicolay K; Grüll H
Invest Radiol; 2016 Nov; 51(11):735-745. PubMed ID: 27309776
[TBL] [Abstract][Full Text] [Related]
6. Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies.
Fossheim SL; Il'yasov KA; Hennig J; Bjørnerud A
Acad Radiol; 2000 Dec; 7(12):1107-15. PubMed ID: 11131055
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
[TBL] [Abstract][Full Text] [Related]
8. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound.
Negussie AH; Yarmolenko PS; Partanen A; Ranjan A; Jacobs G; Woods D; Bryant H; Thomasson D; Dewhirst MW; Wood BJ; Dreher MR
Int J Hyperthermia; 2011; 27(2):140-55. PubMed ID: 21314334
[TBL] [Abstract][Full Text] [Related]
9. Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.
Parac-Vogt TN; Kimpe K; Laurent S; Piérart C; Elst LV; Muller RN; Binnemans K
Eur Biophys J; 2006 Jan; 35(2):136-44. PubMed ID: 16217648
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive magnetic resonance imaging follow-up of sono-sensitive liposome tumor delivery and controlled release after high-intensity focused ultrasound.
Fowler RA; Fossheim SL; Mestas JL; Ngo J; Canet-Soulas E; Lafon C
Ultrasound Med Biol; 2013 Dec; 39(12):2342-50. PubMed ID: 24246245
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: targeted MRI contrast agents for the liver.
Kabalka GW; Buonocore E; Hubner K; Davis M; Huang L
Magn Reson Med; 1988 Sep; 8(1):89-95. PubMed ID: 3173073
[TBL] [Abstract][Full Text] [Related]
12. Monitoring phospholipase A₂ activity with Gd-encapsulated phospholipid liposomes.
Cheng Z; Tsourkas A
Sci Rep; 2014 Nov; 4():6958. PubMed ID: 25376186
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents.
Schwendener RA; Wüthrich R; Duewell S; Wehrli E; von Schulthess GK
Invest Radiol; 1990 Aug; 25(8):922-32. PubMed ID: 2394576
[TBL] [Abstract][Full Text] [Related]
14. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging.
Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380
[TBL] [Abstract][Full Text] [Related]
15. Stabilized porous liposomes with encapsulated Gd-labeled dextran as a highly efficient MRI contrast agent.
Cheng Z; Al Zaki A; Jones IW; Hall HK; Aspinwall CA; Tsourkas A
Chem Commun (Camb); 2014 Mar; 50(19):2502-4. PubMed ID: 24457826
[TBL] [Abstract][Full Text] [Related]
16. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
[TBL] [Abstract][Full Text] [Related]
17. T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration.
Ghaghada K; Hawley C; Kawaji K; Annapragada A; Mukundan S
Acad Radiol; 2008 Oct; 15(10):1259-63. PubMed ID: 18790397
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution and clearance of liposomal gadolinium-DTPA.
Unger E; Cardenas D; Zerella A; Fajardo LL; Tilcock C
Invest Radiol; 1990 Jun; 25(6):638-44. PubMed ID: 2354925
[TBL] [Abstract][Full Text] [Related]
19. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
[TBL] [Abstract][Full Text] [Related]
20. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications.
Zheng J; Perkins G; Kirilova A; Allen C; Jaffray DA
Invest Radiol; 2006 Mar; 41(3):339-48. PubMed ID: 16481918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
